Keywords: smc, approves, s-p, remicade, psoriasis, scottish, medicines
SMC approves S-P's Remicade in psoriasis
Article | 21 May 2007
The Scottish Medicines Consortium (SMC) has recommended approval of US drug major Schering-Plough's Remicade (infliximab) for restricted use within the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
